# Hilton Grand Vacations Inc.: financial statements, quarterly

HGV · NYSE · CIK 1674168 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hgv.md) · [Financials](/companies/hgv/financials.md) · [Filings](/companies/hgv/filings.md) · [Insiders](/companies/hgv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hgv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [633 d](/filings/0001674168-26-000017.md) | [1,034](/filings/0001628280-25-021544.md) | [1,106](/filings/0001674168-25-000007.md) | [1,176](/filings/0001674168-25-000019.md) | [1,149 d](/filings/0001674168-26-000017.md) | [1,015](/filings/0001674168-26-000065.md) | [1,138](/filings/0001674168-26-000100.md) | [1,168](/filings/0001674168-26-000108.md) | [1,192 d](/filings/0001674168-26-000017.md) | [1,136](/filings/0001674168-26-000065.md) | [1,208](/filings/0001674168-26-000100.md) | [1,808](/filings/0001674168-26-000108.md) |
| Interest expense | $m | [45.0 d](/filings/0001628280-24-007940.md) | [79.0](/filings/0001628280-24-022140.md) | [87.0](/filings/0001674168-25-000007.md) | [84.0](/filings/0001674168-25-000019.md) | [79.0 d](/filings/0001674168-26-000017.md) | [77.0](/filings/0001674168-26-000065.md) | [79.0](/filings/0001674168-26-000100.md) | [79.0](/filings/0001674168-26-000108.md) | [76.0 d](/filings/0001674168-26-000017.md) | [73.0](/filings/0001674168-26-000065.md) | [70.0](/filings/0001674168-26-000100.md) | [78.0](/filings/0001674168-26-000108.md) |
| Income tax | $m | [40.0 d](/filings/0001674168-26-000017.md) | [(11.0)](/filings/0001628280-25-021544.md) | [3.0](/filings/0001674168-25-000007.md) | [61.0](/filings/0001674168-25-000019.md) | [23.0 d](/filings/0001674168-26-000017.md) | [6.0](/filings/0001674168-26-000065.md) | [15.0](/filings/0001674168-26-000100.md) | [15.0](/filings/0001674168-26-000108.md) | [40.0 d](/filings/0001674168-26-000017.md) | [6.0](/filings/0001674168-26-000065.md) | [8.0](/filings/0001674168-26-000100.md) | [117](/filings/0001674168-26-000108.md) |
| Net income | $m | [68.0 d](/filings/0001674168-26-000017.md) | [(4.0)](/filings/0001628280-25-021544.md) | [2.0](/filings/0001674168-25-000007.md) | [29.0](/filings/0001674168-25-000019.md) | [20.0 d](/filings/0001674168-26-000017.md) | [(17.0)](/filings/0001674168-26-000065.md) | [25.0](/filings/0001674168-26-000100.md) | [25.0](/filings/0001674168-26-000108.md) | [48.0 d](/filings/0001674168-26-000017.md) | [66.0](/filings/0001674168-26-000065.md) | [12.0](/filings/0001674168-26-000100.md) | [291](/filings/0001674168-26-000108.md) |
| Diluted EPS | $ per share | not reported | [(0.04)](/filings/0001628280-25-021544.md) | [0.02](/filings/0001674168-25-000007.md) | [0.28](/filings/0001674168-25-000019.md) | not reported | [(0.17)](/filings/0001674168-26-000065.md) | [0.25](/filings/0001674168-26-000100.md) | [0.28](/filings/0001674168-26-000108.md) | not reported | [0.79](/filings/0001674168-26-000065.md) | [0.15](/filings/0001674168-26-000100.md) | [3.70](/filings/0001674168-26-000108.md) |
| Basic EPS | $ per share | not reported | [(0.04)](/filings/0001628280-25-021544.md) | [0.02](/filings/0001674168-25-000007.md) | [0.28](/filings/0001674168-25-000019.md) | not reported | [(0.17)](/filings/0001674168-26-000065.md) | [0.26](/filings/0001674168-26-000100.md) | [0.28](/filings/0001674168-26-000108.md) | not reported | [0.81](/filings/0001674168-26-000065.md) | [0.15](/filings/0001674168-26-000100.md) | [3.78](/filings/0001674168-26-000108.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001674168-26-000017.md) | [0.4](/filings/0001628280-25-021544.md) | [0.3](/filings/0001674168-25-000007.md) | [0.3](/filings/0001674168-25-000019.md) | [0.3](/filings/0001674168-26-000017.md) | [0.3](/filings/0001674168-26-000065.md) | [0.3](/filings/0001674168-26-000100.md) | [0.2](/filings/0001674168-26-000108.md) | [0.2](/filings/0001674168-26-000108.md) | [0.3](/filings/0001674168-26-000065.md) | [0.3](/filings/0001674168-26-000100.md) | [0.2](/filings/0001674168-26-000108.md) |
| Total assets | $bn | [8.7](/filings/0001628280-25-009254.md) | [11.7](/filings/0001628280-24-022140.md) | [11.5](/filings/0001628280-24-036019.md) | [11.2](/filings/0001628280-24-046168.md) | [11.4](/filings/0001674168-26-000017.md) | [11.8](/filings/0001628280-25-021544.md) | [11.7](/filings/0001674168-25-000007.md) | [11.7](/filings/0001674168-25-000019.md) | [11.5](/filings/0001674168-26-000108.md) | [11.9](/filings/0001674168-26-000065.md) | [12.2](/filings/0001674168-26-000100.md) | [11.8](/filings/0001674168-26-000108.md) |
| Total liabilities | $bn | [6.6](/filings/0001628280-25-009254.md) | [9.5](/filings/0001628280-24-022140.md) | [9.4](/filings/0001628280-24-036019.md) | [9.2](/filings/0001628280-24-046168.md) | [9.5](/filings/0001674168-26-000017.md) | [10.1](/filings/0001628280-25-021544.md) | [10.1](/filings/0001674168-25-000007.md) | [10.1](/filings/0001674168-25-000019.md) | [10.1](/filings/0001674168-26-000108.md) | [10.6](/filings/0001674168-26-000065.md) | [11.0](/filings/0001674168-26-000100.md) | [10.3](/filings/0001674168-26-000108.md) |
| Long-term debt | $bn | [3.0](/filings/0001628280-25-009254.md) | [5.1](/filings/0001628280-24-022140.md) | [4.9](/filings/0001628280-24-036019.md) | [5.0](/filings/0001628280-24-046168.md) | [4.6](/filings/0001674168-26-000017.md) | [4.5](/filings/0001628280-25-021544.md) | [4.6](/filings/0001674168-25-000007.md) | [4.7](/filings/0001674168-25-000019.md) | [4.5](/filings/0001674168-26-000108.md) | [4.8](/filings/0001674168-26-000065.md) | [4.9](/filings/0001674168-26-000100.md) | [4.9](/filings/0001674168-26-000108.md) |
| Shareholders' equity | $bn | [2.1](/filings/0001628280-25-009254.md) | [2.0](/filings/0001628280-24-022140.md) | [1.9](/filings/0001628280-24-036019.md) | [1.8](/filings/0001628280-24-046168.md) | [1.8](/filings/0001674168-26-000017.md) | [1.6](/filings/0001628280-25-021544.md) | [1.5](/filings/0001674168-25-000007.md) | [1.4](/filings/0001674168-25-000019.md) | [1.3](/filings/0001674168-26-000108.md) | [1.2](/filings/0001674168-26-000065.md) | [1.1](/filings/0001674168-26-000100.md) | [1.3](/filings/0001674168-26-000108.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.0 d](/filings/0001674168-26-000017.md) | [0.0](/filings/0001628280-25-021544.md) | [113 d](/filings/0001674168-25-000007.md) | [91.0 d](/filings/0001674168-25-000019.md) | [105 d](/filings/0001674168-26-000017.md) | [38.0](/filings/0001674168-26-000065.md) | [61.0 d](/filings/0001674168-26-000100.md) | [34.0 d](/filings/0001674168-26-000108.md) | [167 d](/filings/0001674168-26-000017.md) | [128](/filings/0001674168-26-000065.md) | [134 d](/filings/0001674168-26-000100.md) | [87.0 d](/filings/0001674168-26-000108.md) |
| Capital expenditure | $m | [13.0 d](/filings/0001674168-26-000017.md) | [10.0](/filings/0001628280-25-021544.md) | [7.0 d](/filings/0001674168-25-000007.md) | [10.0 d](/filings/0001674168-25-000019.md) | [15.0 d](/filings/0001674168-26-000017.md) | [14.0](/filings/0001674168-26-000065.md) | [15.0 d](/filings/0001674168-26-000100.md) | [21.0 d](/filings/0001674168-26-000108.md) | [20.0 d](/filings/0001674168-26-000017.md) | [6.0](/filings/0001674168-26-000065.md) | [3.0 d](/filings/0001674168-26-000100.md) | [14.0 d](/filings/0001674168-26-000108.md) |
| Share repurchases | $m | [100 d](/filings/0001674168-26-000017.md) | [99.0](/filings/0001628280-25-021544.md) | [100 d](/filings/0001674168-25-000007.md) | [108 d](/filings/0001674168-25-000019.md) | [125 d](/filings/0001674168-26-000017.md) | [150](/filings/0001674168-26-000065.md) | [150 d](/filings/0001674168-26-000100.md) | [150 d](/filings/0001674168-26-000108.md) | [150 d](/filings/0001674168-26-000017.md) | [150](/filings/0001674168-26-000065.md) | [150 d](/filings/0001674168-26-000100.md) | [110 d](/filings/0001674168-26-000108.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [114](/filings/0001628280-24-022140.md) | [112](/filings/0001628280-24-036019.md) | [111](/filings/0001628280-24-046168.md) | [105](/filings/0001628280-25-021544.md) | [104](/filings/0001674168-25-000007.md) | [102](/filings/0001674168-25-000019.md) | [95.5](/filings/0001674168-26-000065.md) | [92.2](/filings/0001674168-26-000100.md) | [90.1](/filings/0001674168-26-000108.md) | [83.7](/filings/0001674168-26-000065.md) | [80.9](/filings/0001674168-26-000100.md) | [78.6](/filings/0001674168-26-000108.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 75,822,729 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0001674168-26-000108.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 03:15 ET. No prices; not investment advice.